Company Description
DocGo Inc. (NASDAQ: DCGO) is a provider of technology-enabled mobile health and medical transportation services. The company focuses on delivering care outside traditional clinical settings through a care delivery platform that combines mobile health services, remote patient monitoring, ambulance and medical transport services, and a 50‑state virtual care network, as described in its public communications and SEC filings.
According to company disclosures, DocGo aims to help reshape the traditional four‑wall healthcare system by bringing high quality, highly accessible care to patients where and when they need it. Its model relies on proprietary technology and relationships with a dedicated field staff of certified health professionals to support patient care and to drive business efficiencies for facilities, hospital networks, municipalities and health insurance providers.
Business model and core services
DocGo’s business is built around a care delivery platform that enables healthcare to be provided in non‑traditional locations. The company reports that its platform includes:
- Mobile Health Services – healthcare services performed at homes, offices and other locations, as well as event services such as on‑site healthcare support at sporting events and concerts. These services are described as a major revenue contributor in the company’s segment reporting.
- Transportation Services – ambulance and broader medical transportation services, including integrated Ambulnz medical transport services. DocGo has highlighted dedicated ambulance services and coordination of discharge transportation for hospital partners through a digital transportation management platform.
- Virtual Care and Remote Patient Monitoring – a 50‑state virtual care network and remote patient monitoring capabilities that allow clinicians and advanced practice providers to supervise care delivered in the home or workplace.
The company has stated that it operates through three reporting segments: Mobile Health Services, Transportation Services, and Corporate. It has also indicated that a majority of its revenue has been generated from the Mobile Health Services segment, with additional revenue from Transportation Services. DocGo has reported that it generates most of its revenue in the United States, with the remainder from the United Kingdom.
Care delivery approach
In multiple press releases, DocGo describes itself as “leading the proactive healthcare revolution” by combining mobile care teams, telehealth, and medical transportation. With Mobile Health, the company states that it facilitates healthcare treatment in tandem with a remote physician or advanced practice provider in the comfort of a patient’s home or workplace. This approach is presented as a way to empower the full promise of telehealth by pairing virtual visits with in‑person clinical support.
DocGo also emphasizes programs such as care gap closure services, transitions of care, mobile phlebotomy, vaccination programs, and longitudinal care offerings. Public disclosures reference contracts with payer and provider partners to engage large numbers of patients for care gap closure services, as well as initiatives with insurance plans, academic medical systems, municipalities and federal or local health agencies to provide in‑home and mobile care.
Technology and clinical workforce
The company highlights its proprietary technology as a key component of its platform. In its public statements, DocGo notes that this technology supports dispatch, coordination and management of mobile health visits and medical transportation, and underpins offerings such as a digital transportation management platform used in multi‑year ambulance contracts.
DocGo also points to its relationships with a dedicated field staff of certified health professionals and affiliated clinical practice groups. These clinicians provide on‑site services, often supported by connected diagnostic equipment and supervised by remote advanced practice providers through the virtual care network. The combination of mobile clinicians and telehealth is described as central to programs such as care gap closure, chronic care management, and longitudinal care services.
Recent strategic developments and programs
Company news releases and SEC filings describe several notable developments that illustrate how DocGo applies its business model:
- Care gap closure and population health programs – DocGo has reported launching and expanding care gap closure programs with insurance providers in regions such as Southern California and the Northeast, including primary care services and transitions of care. It has also referenced work with public health plans and tribal and state health departments to expand access to preventive wellness care, women’s health, chronic disease management and behavioral health services.
- Medical transportation contracts – The company has highlighted multi‑year contracts with academic medical systems in the New York metro area for dedicated ambulance services and discharge transportation coordination, as well as contracts with municipalities for 911 basic life support services and agreements with federal medical centers for medical transportation.
- Longitudinal care services – DocGo has announced plans to launch longitudinal care services for a major California health plan, using on‑site mobile clinicians and telehealth to deliver preventative care, chronic care management and transitions of care for plan members who are under‑engaged in their own care.
- Acquisition of SteadyMD – Through its subsidiary Ambulnz Holdings, LLC, DocGo entered into an Agreement and Plan of Merger to acquire SteadyMD, Inc., a virtual care platform. Company disclosures state that SteadyMD offers a 50‑state virtual clinician workforce, clinical operations and technology that matches patient needs with clinical expertise, and that this acquisition is intended to expand DocGo’s telehealth capabilities and virtual provider network.
Geographic and customer focus
DocGo’s public materials indicate that the company serves customers primarily in the United States, with additional operations in the United Kingdom. It references working with hospital networks, health insurance providers, municipalities, academic medical systems, public health plans, federal medical centers, and digital health and wellness brands (through SteadyMD). These relationships are presented as a way to reach patients in their homes and communities, particularly those facing barriers to accessing traditional healthcare settings.
Capital markets and corporate structure
According to its SEC filings, DocGo Inc. is a Delaware corporation whose common stock trades on The Nasdaq Stock Market LLC under the ticker symbol DCGO. The company has disclosed a share repurchase program authorized by its Board of Directors, with the expiration date extended to June 30, 2026, and has reported using cash flows and balance sheet resources to fund repurchases and strategic transactions.
DocGo files periodic and current reports with the U.S. Securities and Exchange Commission, including Forms 10‑K, 10‑Q and 8‑K, which provide additional detail on its segment reporting, financial condition, contracts and risk factors. The company has also reported holding annual meetings of stockholders at which matters such as director elections, executive compensation advisory votes and auditor ratification are presented for shareholder approval.
Position within the healthcare and medical transport sector
Based on its own descriptions, DocGo operates at the intersection of mobile healthcare services, telehealth and medical transportation. By combining mobile clinicians, remote patient monitoring, a virtual care network and ambulance services, the company positions its platform as a way to bridge the gap between physical and virtual care. Its emphasis on care gap closure, transitions of care and longitudinal care programs reflects a focus on helping payers and providers engage patients outside traditional clinical environments.
FAQs about DocGo Inc. (DCGO)
- What does DocGo Inc. do?
DocGo Inc. provides technology‑enabled mobile health and medical transportation services. According to its public statements, its care delivery platform includes mobile health services, remote patient monitoring, ambulance and medical transport services, and a 50‑state virtual care network. - How does DocGo generate revenue?
The company reports that it operates through Mobile Health Services, Transportation Services and Corporate segments. It has disclosed that a majority of its revenue has been generated from the Mobile Health Services segment, with additional revenue from Transportation Services, primarily in the United States. - What are DocGo’s main service lines?
DocGo highlights mobile health services delivered at homes, workplaces and events; ambulance and broader medical transportation services; remote patient monitoring; and virtual care through a 50‑state network. It also emphasizes programs such as care gap closure, transitions of care, mobile phlebotomy, vaccination initiatives and longitudinal care services. - Who are DocGo’s typical customers and partners?
In its press releases, DocGo references working with hospital networks, academic medical systems, health insurance providers, public health plans, municipalities, federal medical centers, tribal and state health departments, and digital health and wellness brands (through SteadyMD). - What is the role of technology in DocGo’s business?
The company describes using proprietary technology to coordinate mobile health visits, manage medical transportation and support its virtual care network. It also references a digital transportation management platform used in multi‑year ambulance contracts and technology that matches patient needs with clinical expertise through the SteadyMD acquisition. - How does DocGo support telehealth services?
DocGo states that its Mobile Health services empower telehealth by pairing remote physicians or advanced practice providers with on‑site clinicians in patients’ homes or workplaces. The company also notes that it operates a 50‑state virtual care network and, through SteadyMD, a nationwide virtual clinician workforce. - What is DocGo’s stock symbol and where is it listed?
According to SEC filings, DocGo Inc.’s common stock trades on The Nasdaq Stock Market LLC under the ticker symbol DCGO. - Has DocGo engaged in share repurchases?
Yes. An 8‑K filed in December 2025 states that DocGo’s Board of Directors approved an extension of the expiration date of the company’s share repurchase program, under which the company may purchase up to a specified dollar amount of its common stock through various methods. - What acquisition activity has DocGo disclosed?
In October 2025, DocGo, through its wholly owned subsidiary Ambulnz Holdings, LLC, entered into an Agreement and Plan of Merger to acquire SteadyMD, Inc., a virtual care platform. SEC filings describe the transaction terms and note that SteadyMD merged with a DocGo subsidiary. - Where can investors find more detailed information on DocGo?
Investors can review DocGo’s filings with the U.S. Securities and Exchange Commission, including Forms 10‑K, 10‑Q and 8‑K, which provide detailed information on its financial performance, segment results, risk factors and material events.
Stock Performance
DOCGO (DCGO) stock last traded at $0.7775, up 19.55% from the previous close. Over the past 12 months, the stock has lost 72.8%. At a market capitalization of $63.3M, DCGO is classified as a micro-cap stock with approximately 97.8M shares outstanding.
Latest News
DOCGO has 10 recent news articles, with the latest published yesterday. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, earnings date, conferences. View all DCGO news →
SEC Filings
DOCGO has filed 5 recent SEC filings, including 2 Form 8-K, 1 Form 4, 1 Form 10-K, 1 Form SCHEDULE 13D/A. The most recent filing was submitted on March 16, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all DCGO SEC filings →
Financial Highlights
DOCGO generated $322.2M in revenue over the trailing twelve months, operating income reached -$178.0M (-55.3% operating margin), and net income was -$182.4M, reflecting a -56.6% net profit margin. Diluted earnings per share stood at $-1.84. The company generated $34.5M in operating cash flow. With a current ratio of 2.26, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in DOCGO (DCGO) currently stands at 5.8 million shares, down 0.9% from the previous reporting period, representing 6.2% of the float. The 6.2 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for DOCGO (DCGO) currently stands at 6.2 days, down 41.6% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has decreased 26% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 14.5 days.
DCGO Company Profile & Sector Positioning
DOCGO (DCGO) operates in the Medical Care Facilities industry within the broader Services-health Services sector and is listed on the NASDAQ.
Investors comparing DCGO often look at related companies in the same sector, including Biote (BTMD), Joint Corp (JYNT), The Oncology Institute Inc (TOI), Cross Ctry Healthcare Inc (CCRN), and Enhabit (EHAB). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate DCGO's relative position within its industry.